Renal clear cell carcinoma with weak to moderate NSE positivity in 30% of tumor cells.

Strong NSE immunostaining in all cells of a castration resistant prostate cancer.

Strong NSE immunostaining in all cells of a renal clear cell carcinoma.

Strong NSE immunostaining in all tumor cells of a seminoma of the testis.

Strong NSE positivity in all cells of a small cell carcinoma of the urinary bladder.